Immunome Inc. (IMNM)
NASDAQ · Healthcare
Immunome Inc. Net Income 2023–2025
Immunome Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Immunome Inc. net income for the quarter ending March 31, 2026 was -53.8 M, a 29.30% increase year-over-year.
- Immunome Inc. net income for the twelve months ending March 31, 2026 was -196.3 M, a 9.55% decrease year-over-year.
- Immunome Inc. annual net income for 2025 was -212.4 M, a 27.50% decrease from 2024.
- Immunome Inc. annual net income for 2024 was -293.0 M, a 174.29% increase from 2023.
- Immunome Inc. annual net income for 2023 was -106.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Immunome Inc. Net Income — FAQ
Immunome Inc. (IMNM) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Immunome Inc.'s net income?
Immunome Inc. (IMNM) reported net income of -$212M for fiscal 2025.
Where can I see IMNM's net income history?
The chart and table above show Immunome Inc.'s net income by year and by quarter, including the growth rate.